Abstract
Background The privacy protection of medical patients has remained a critical concern in healthcare information management during the digital era. Conventional approaches have predominantly relied on rule-based protocols and data encryption systems, which typically require substantial involvement of IT professionals for implementation. Recent advancements in Large Language Models (LLMs) have introduced novel approaches for electronic medical records (EMRs) privacy protection, simultaneously enabling clinical practitioners to utilize these tools for specific data tasks.
Objectives This study aims to leverage LLMs through a no-code framework to achieve structured processing of patient privacy data in Chinese EMRs and formulate privacy policies, while evaluating the practical efficacy of LLMs.
Methods This study employs a disease-specific data subset from Peking Union Medical College Hospital (PUMCH), comprising data from approximately 160,000 patients, using a prompt engineering approach to enable LLMs to perform sensitive information annotation in lengthy EMR narratives. Simultaneously, it automates the classification of privacy-level for identified sensitive data and develops targeted protection strategies based on risk tiers, thereby mitigating non-essential exposure of patient privacy during data sharing. The research utilizes the Qwen model, with its entire workflow being exclusively driven by medical natural language prompts and self-evolving knowledge bases, requiring no supplementary programming or code development. These strategies were validated using the hospital’s test text dataset, with primary evaluation metrics focusing on precision rates (including accuracy of information extraction and privacy-level classification) and recall rate assessments for critical sensitive data categories.
Results Utilizing 4 million text entries from PUMCH, we conducted sampled data observation and performed privacy annotation via LLM prompts across seven categories: names, addresses, contact details, national ID numbers, hospital names, sexually transmitted disease (STD) information, and pregnancy-related patient data. Through iterative prompt refinement via error analysis, optimal performance was achieved on the test set, demonstrating an average precision of 97% and recall of 95% across these seven entity types. Furthermore, sensitivity tier classification was implemented for three high-risk categories: addresses, STD information, and pregnancy-related data, attaining average precision of 95% and recall of 90% in sensitivity-level determination.
Discussion We propose a novel codeless privacy protection framework leveraging LLMs, enabling intelligent anonymization of medical data through natural language interaction. This solution employs a three-tiered hierarchical protection mechanism that dynamically adapts privacy strategies to clinical scenario requirements, ensuring data security while maximizing data utility.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was supported by the National Key Research and Development Program of China (2023YFC2706305).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This study has been approved by the Ethics Review Committee of Peking Union Medical College Hospital, Chinese Academy of Medical Sciences
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
The datasets supporting the findings of this study are available from the corresponding author upon reasonable request. The hospital data cannot be made publicly available due to its sensitive nature.





